FDA Approves Therapy to Treat Gaucher Disease The U.S. Food
FDA Approves Therapy to Treat Gaucher Disease
The U.S. Food and Drug Administration has approved velaglucerase alfa for injection (VPRIV) to treat children and adults with a form of the rare genetic disorder Gaucher disease.